Andrew Lane - New EPF President
Andrew Lane has been appointed as the new president of the EPF, succeeding João Silveira who is stepping down as President after completing his three-year term in the role. Andrew, an independent pharmacist from South-West England and a member of the Alphega Pharmacy network, was elected during the latest EPF seminar, which took place on 6 and 7 October 2011 in Barcelona.
Two new vice presidents were also appointed at the seminar: Walter Taeschner (Germany) and Marco Nocentini Mungai (Italy), who replace former vice presidents Giancarlo Visini and Frank Owens.
Commenting on his appointment, Andrew said: "The next few years will be critical for pharmacy to prove through good outcomes that it delivers great value to patients and payors alike. The EPF will be a valuable resource to assist this process with data that can be trusted to evidence these outcomes. I am looking forward to serving the EPF members in the next 3 years by calling on my practice experience and European networks."
Outgoing president João Silveira also commented: "Pharmacy has seen some unprecedented changes and many challenges during my term as president. However I hand over this role to Andrew confident that through the EPF we have been able to give pharmacy a strong and collective voice across Europe and will continue to do so."
Highlights from the Barcelona Forum:
At the third EPF seminar of 2011 current issues common to pharmacists across Europe were addressed; in particular focussing on pressures to government healthcare expenditure and its impact to pharmacy and the pharmaceutical industry. Industry leaders from Spain also gave a focus overview on the particular challenges for their home market.
On Day 1 of the seminar Stefano Dessena (Managing Director of Alliance Healthcare España) gave an update on the pharmaceutical wholesaling market in Spain and was then followed by Ana Aliaga (Secretary General, Consejo General de Colegios Oficiales de Farmacéuticos – General Council of Official Pharmacists), who explained the changing role of Pharmacy in Spain. The focus then shifted to product manufacturing, with Sergio Dompé (Chairman of Dompé Farmaceutici S.p.A) presenting on the evolution and impact of biotechnological products on the pharmaceutical business. Tony Foreman (Commercial Director, Alliance Healthcare Division and CEO, Almus Pharmaceuticals), then outlined the future development and impact of Generic medicines and pricing structures in the coming years, particularly on the wholesaling and pharmacy markets.
Later in the day Alfonso Jiménez Palacios (Director General of Farmacia y Production Sanitarios – Spanish Ministry of Health) gave a presentation looking at the Spanish health system and the impact to pharmacy and distribution from the economic crisis. Ornella Barra (Chief Executive, Pharmaceutical Wholesale Division, Alliance Boots) then concluded the first day by providing an update on Alliance Boots recent activities.
The second day of the EPF focussed on the forum's regular workshops, looking at their three key areas for pharmacy; Pharmacy Partnerships, Pharmacy Profession and Pharmacy Business.
Ornella Barra commented: "Many European economies are under renewed pressure and this understandably is having a continued impact on Government healthcare expenditure. Pharmacists across Europe are experiencing many similar challenges in light of these pressures and the EPF offers an opportunity for us all to share our own experiences and understand how we can all continue to drive pharmacy forward even in these difficult times."
For further information please contact:
Sanam Conway: PR Manager, Alliance Boots
Tel: +44 (0)1932 871400